ResearchAndMarkets.com added two reports covering related but distinct markets. The global artificial intelligence in healthcare market is projected to grow from $36.67 billion in 2026 to $194.79 billion by 2031 at a 39.7% compound annual growth rate, while India’s AI-enabled clinical trials market is forecast to expand from $140 million in the current year to $803 million by 2035 at approximately 21.4% CAGR. The global report highlights adoption across clinical documentation, diagnostics, decision support, patient management, imaging and workflow optimization, with cloud deployment, hospitals and clinics, and Asia Pacific leading respective segments. The India report identifies oncology, cloud-based platforms, pharmaceutical and biotechnology companies, and contract research organizations as major or fast-growing segments, with South and West India leading current deployment and North India expected to expand rapidly. Both reports cite digitization, investment and efficiency gains as growth drivers, while data privacy, interoperability, regulatory complexity and shortages of specialized personnel remain constraints.